Plexus Q3 Results Underscore Growth Stagnation, Margin Stability Alone Not Enough

What happened

Plexus Corp. reported fiscal third-quarter 2026 revenue of $1.02 billion, at the lower end of its guidance range, while non-GAAP operating margin held steady at 5.8%. Free cash flow came in at $23 million, pressured by a $40 million working-capital build that pushed the year-to-date FCF to only $55 million, well off the pace needed to hit the $100 million full-year target. EMEA revenue continued to decline, dropping 12% year over year, offsetting modest gains in the Americas and APAC, and management attributed the sequential shortfall to slower-than-expected conversion of recent program wins. The company maintained a net cash position but did not repurchase shares during the quarter, citing a focus on internal investments, while the effective tax rate remained elevated at 19%. These results confirm that the promised acceleration to 9-12% revenue growth remains elusive, leaving the stock vulnerable to multiple compression given its 28x trailing P/E.

Implication

The Q3 print reaffirms the slow-growth reality: revenue is tracking toward mid-single-digit gains for FY2026, well short of the 9-12% target, and free cash flow is likely to miss the $100 million guide unless working capital reverses dramatically. While margins appear durable around 5.8-6.0%, that alone does not support a 28x P/E when growth is missing. Investors should view any post-earnings pop as an opportunity to reduce positions above $190, as the bear-case scenario of $130 becomes more probable if the next two quarters fail to show a clear ramp in win conversion. For new money, wait for a pullback toward the $150–160 entry level where the FCF yield tightens and the risk/reward improves.

Thesis delta

The thesis shifts slightly more bearish: Q3 results offer no evidence that the large annualized program wins are translating into above-market revenue growth, which is the core bull case. With free cash flow tracking well below expectations and EMEA weakness persisting, the margin of safety at current levels has narrowed further. The burden of proof now rests squarely on management’s Q4 guidance to demonstrate a credible path to 9-12% growth; otherwise, a de-rating toward the mid-$130s is increasingly likely.